
医学资讯CONDOR试验增殖性糖尿病视网膜病变
布罗鲁西单抗在增殖性糖尿病视网膜病变中优于激光疗法:来自CONDOR试验的见解
By MedXY|2026年4月27日
CONDOR试验表明,布罗鲁西单抗在保护视力和减少增殖性糖尿病视网膜病变进展方面优于全视网膜光凝术,可能改变治疗范式。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.